S
Synthace
Engineering biology for health, food, energy and manufacturing.
About Synthace
Synthace operates in the life sciences sector, providing a cloud-based software platform designed to automate experimentation and facilitate insight sharing. The platform, known as Synthace Life Sciences R&D Cloud, enables scientists to create and share automated workflows without needing programming or automation expertise. This allows researchers to focus on impactful work by reducing the time and effort required for manual processes. The platform supports advanced experimental designs like Design of Experiments (DOE) and Quality by Design (QbD), which help in testing multiple factors and their interactions simultaneously. Synthace serves life science researchers and organizations looking to enhance their R&D capabilities, improve data reproducibility, and maximize the efficiency of their experimental processes. The company generates revenue through subscription fees for its software platform, targeting a market that includes academic institutions, biotech firms, and pharmaceutical companies.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2011
- Headquarters
- London, United Kingdom
- Employees
- 37
- Open positions
- None listed
- Dealroom signal
- 68.6/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Drug Development, Core AI, Synthetic Biology, Spinout
- Technology
- Artificial Intelligence, Hardware, Deep Tech, Machine Learning, Nanotech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Aug 2025 | $5.7M | $172M | Undisclosed | ↗ |
| SERIES COther financing | Nov 2021 | $35M | $140M | Sofinnova Partners · Horizons Ventures | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Synthace is 8.4K monthly website visits, up 5% over the last three months. Synthace's team grew 2.8% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed5 investors entered at this stage
Sofinnova Partners
Keith Willey
Sami Mikati
Michail Eleftheriou- DLDavid Lucas
Series A9 investors entered at this stage
John Taysom
SOSV
Future Planet Capital
Luminous Ventures- ECEleven Two Capital
Amadeus Capital Partners
White Cloud Capital- BVBioeconomy Capital Sustainable Conversion Ventures
Horizons Ventures
Other known investors2 additional known investors
Tech Nation
University College London
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Synthace on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Synthace’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.